{"listing":{"listing_type":"company","name":"Exin Therapeutics","slug":"exin-therapeutics","tagline":"AI drug discovery platform for neurotherapeutics","description":"We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house.\n\nWe are 3 Oxford-trained neuroscientists supported by an experienced SAB from Harvard, Science Corp (ex-Neuralink), EPFL, Meta, and UCL.\n\nIn 1.5 months since landing in SF, we went from nothing to (1) opening and operating an animal lab in South SF, (2) obtaining a proof-of-concept in mice, (3) building a multimodal AI model that directs our screening approach and (4) submitting two provisional patents; all while utilizing less than 50% of our YC funding.\n\nExin Therapeutics is a Y Combinator company (Winter 2025). YC-listed status: Active.","url":"https://www.exintherapeutics.com/","is_stealth":false,"normalized_domain":"exintherapeutics.com","normalized_url_key":"exintherapeutics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/61d9c34b51f9b98cbfdb92bc0014e3569c29b36c.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/exin-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.exintherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.exintherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Neurotechnology","Biotech"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:54:21.458Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2025","Neurotechnology","Biotech","Therapeutics"],"one_liner_for_search":"Exin Therapeutics — AI drug discovery platform for neurotherapeutics (Y Combinator Winter 2025)","canonical_facts":["Y Combinator batch: Winter 2025","YC company status: Active","Team size (per YC directory): 9","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: EI Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:54:21.458Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"neurotechnology","name":"Neurotechnology","note":null,"profile_url":"/industries/neurotechnology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}]}}